<DOC>
	<DOC>NCT01705639</DOC>
	<brief_summary>The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants of the melatonin receptor 1B gene will be evaluated. The following will be done at 0 and 3 months: - OGTT - questionnaires about sleep and activity - Actigraph - Anthropometry - Blood pressure</brief_summary>
	<brief_title>Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene</brief_title>
	<detailed_description>http://www.sciencedirect.com/science/article/pii/S1550413116301607</detailed_description>
	<mesh_term>Melatonin</mesh_term>
	<criteria>signed informed concent Known genotype for MTNR1B from the Botniappp study Age 1875 years Diabetes Positive GADab Sever dysregulated hypertension glaucoma severe coronary heart disease or arrythmias previous or ongoing severe ventricle or duodenal ulcer psychosis or anxiety disorder regular use of sleep pills, antidepressants or neuroleptics creatinine &gt; 130 Âµmol/L elevated liver enzymes (ASAT, ALAT, ALP, GT, bilirubin) &gt; 3 times reference value inability to sign informed concent other factor with according to the physician may affect treatment or results. participation in other clinical study allergy to melatonin or other substance in the capsule hereditary galactose intolerance or glucose/galactose malabsorption intention to become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>diabetes</keyword>
	<keyword>melatonin</keyword>
	<keyword>glucose tolerance</keyword>
	<keyword>sleep</keyword>
</DOC>